Aier Eye Hospital Group Co (300015) Q3 2024 earnings summary

Executive summary

• Revenue for Q3 2024 was ¥5.76 billion, down 0.68% year-over-year; net profit attributable to shareholders was ¥1.40 billion, down 4.56% year-over-year.

• For the first nine months, revenue reached ¥16.30 billion, up 1.58% year-over-year; net profit attributable to shareholders was ¥3.45 billion, up 8.50% year-over-year.

• Cash flow from operating activities for Q3 was ¥4.30 billion, down 22.88% year-over-year.

Financial highlights

• Basic EPS for Q3 was ¥0.1521, down 4.56% year-over-year; for the nine months, ¥0.3746, up 8.49% year-over-year.

• Total assets at quarter-end were ¥32.98 billion, up 9.25% from the previous year-end.

• Owner's equity attributable to shareholders was ¥20.40 billion, up 8.21% from the previous year-end.

• Non-recurring profit for the nine months was ¥338.69 million, mainly from financial asset disposals and government subsidies.

Key financial ratios and metrics

• Weighted average ROE for the nine months was 17.37%, down 0.47 percentage points year-over-year.

• Gross margin for the nine months was 51.0%, slightly down from 51.9% year-over-year.